Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-01
DOI
10.1007/s00228-019-02771-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel acute kidney injury biomarkers: their characteristics, utility and concerns
- (2018) Braian M. Beker et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Kidney-protective Effect of Magnesium Supplementation in Cisplatin-containing Chemotherapy for Pediatric Cancer
- (2018) Motohiro Matsui et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- N -acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity
- (2018) Sandra M. Sancho-Martínez et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity
- (2017) C. M. Mach et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer
- (2017) Hasnaa Osama et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Influence of magnesium and parathyroid hormone on cisplatin-induced nephrotoxicity in esophageal squamous cell carcinoma
- (2017) Hirotaka Konishi et al. Oncology Letters
- Vitamin D levels in critically ill patients with acute kidney injury: a protocol for a prospective cohort study (VID-AKI)
- (2017) Lynda Katherine Cameron et al. BMJ Open
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial
- (2016) Yoshitomo Yanagimoto et al. BRITISH JOURNAL OF CANCER
- A H2S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice
- (2016) Mi Liu et al. MEDIATORS OF INFLAMMATION
- The efficacy of theophylline in preventing cisplatin-related nephrotoxicity in patients with cancer
- (2016) Lutfiye Derya Karademir et al. RENAL FAILURE
- Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity
- (2016) Yoshitaka Saito et al. SUPPORTIVE CARE IN CANCER
- Phenotype standardization for drug-induced kidney disease
- (2015) Ravindra L. Mehta et al. KIDNEY INTERNATIONAL
- Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
- (2015) Foroud Shahbazi et al. PHYTOTHERAPY RESEARCH
- Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy
- (2015) Trevor McKibbin et al. SUPPORTIVE CARE IN CANCER
- Protective Effects of Molsidomine Against Cisplatin-Induced Nephrototoxicity*
- (2015) Habib Karakoc et al. Advances in Clinical and Experimental Medicine
- Evaluation of the protective effect of Cystone® against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity
- (2014) Mahmoud A. El-Ghiaty et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Protective Effect of Magnesium Preloading on Cisplatin-induced Nephrotoxicity: A Retrospective Study
- (2014) T. Yoshida et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The economic impact of acute kidney injury in England
- (2014) M. Kerr et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection
- (2014) Yasuhiro Kidera et al. PLoS One
- World Incidence of AKI: A Meta-Analysis
- (2013) P. Susantitaphong et al. Clinical Journal of the American Society of Nephrology
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
- (2013) Rossella Marullo et al. PLoS One
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
- (2011) Penélope D. Sánchez-González et al. CRITICAL REVIEWS IN TOXICOLOGY
- Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity
- (2010) Hiromu Katsuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cisplatin Overdose
- (2009) Roger Y. Tsang et al. DRUG SAFETY
- Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study
- (2008) Lubomir Bodnar et al. EUROPEAN JOURNAL OF CANCER
- Clinical Consequences and Management of Hypomagnesemia
- (2008) K. J. Martin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now